SUSW:LSE:LSE-iShares MSCI World SRI UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 11.145

Change

+0.20 (+1.78)%

Market Cap

N/A

Volume

0.28M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 544.83B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 544.83B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 209.75B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B
0R24:LSE Intel Corp.

N/A

USD 196.14B

ETFs Containing SUSW:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.51% 71% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.51% 70% C- 67% D+
Trailing 12 Months  
Capital Gain 16.06% 71% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.06% 70% C- 68% D+
Trailing 5 Years  
Capital Gain 84.60% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.60% 88% B+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 13.25% 79% B- 78% C+
Dividend Return 13.25% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.68% 50% F 67% D+
Risk Adjusted Return 96.92% 95% A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike